Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

CIViC Variants/c.1641+1dup

c.1641+1dup

CIViC ID: 615 · Gene: JAK2

Variant Summary

HGVS: NC_000009.11:g.5070053_5070054insG
Variant Type(s): —
Evidence Items: 1

Evidence Level Distribution

Level C: 1

Evidence Items

Showing CIViC evidence rows where gene = JAK2 and variant = c.1641+1dup.

Level	Type	Direction	Significance	Disease	Drugs	Rating
C	Predictive	Supports	Resistance	Skin Melanoma	Pembrolizumab	4